Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
The cyclin-dependent kinase inhibitor p16 is a candidate tumour-suppressor protein that maps to a genomic locus strongly associated with familial melanoma and other tumour types. Screening of primary tumours and linkage analysis of familial melanoma pedigrees have identified many potential mutations in p16, but the functional significance of these sequence variants has remained unclear. We report here that p16 can act as a potent and specific inhibitor of progression through the G1 phase of the cell cycle, and we demonstrate that several tumour-derived alleles of p16 encode functionally compromised proteins. The ability of p16 to arrest cell-cycle progression generally correlates with inhibition of cyclin D1/Cdk4 kinase activity in vitro, with two exceptions among the alleles tested. In vivo, the presence of functional retinoblastoma protein appears to be necessary but may not be sufficient to confer full sensitivity to p16-mediated growth arrest. Our results provide support for the notion that p16 is an important cell-cycle regulator whose inactivation contributes to the outgrowth of human tumours.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, cells lacking functional RB were resistant to p16INK4a-mediated cell cycle arrest, implying that the ability of CDK4 (and later, CDK6) to drive G1 phase progression required RB (33-35) and predicting that chemical CDK4/6 inhibitors would show efficacy only if RB were functionally intact.”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [35]
Citations
Cites
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
G1 phase progression: Cycling on cue
Sherr, C. J. (1994) · Cell · doi:10.1016/0092-8674(94)90540-1 · Cited by 2,674
pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
Hannon, G. J., & Beach, D. (1994) · Nature · doi:10.1038/371257a0 · Cited by 1,950
Effects of an Rb mutation in the mouse
Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., & Weinberg, R. A. (1992) · Nature · doi:10.1038/359295a0 · Cited by 1,755
Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53
Baker, S. J., Markowitz, S., Fearon, E. R., Willson, J. K. V., & Vogelstein, B. (1990) · Science · doi:10.1126/science.2144057 · Cited by 1,754
(1993) · Genes & Development · doi:10.1101/gad.7.3.331 · Cited by 1,264
Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., & Kern, S. E. (1994) · Nature Genetics · doi:10.1038/ng0994-27 · Cited by 1,136
Distinct Roles for Cyclin-Dependent Kinases in Cell Cycle Control
van den Heuvel, S., & Harlow, E. (1993) · Science · doi:10.1126/science.8266103 · Cited by 1,092
Functional interactions of the retinoblastoma protein with mammalian D-type cyclins
Ewen, M. E., Sluss, H. K., Sherr, C. J., Matsushime, H., Kato, J.-Y., & Livingston, D. M. (1993) · Cell · doi:10.1016/0092-8674(93)90136-e · Cited by 1,010
Research works printed but not linked: 2
- Mori, T. et al. Canc. Res. 54, 3396–3397 (1994).
- Otterson, G. A., Kratzke, R. A., Coxon, A., Kim, Y. W. & Kaye, F. J. Oncogene 9, 3375–3378 (1994).
Cited by
Items 401–500 of 513
Anwar, F., & Ahmad, U. N. U. (2012) · Cited by 33
Kamoshida, S., Matsuoka, H., Shiogama, K., Matsuyama, A., Shimomura, R., Inada, K., MARUTA, M., & Tsutsumi, Y. (2004) · Pathology International · doi:10.1111/j.1440-1827.2004.01665.x · Cited by 18
Ankyrin for clues about the function 0fp16INK4a
McDonald, N. Q., & Peters, G. G. (1998) · Nature Structural Biology · doi:10.1038/nsb0298-85 · Cited by 13
The retinoblastoma gene family: its role in cancer onset and progression
Cinti, C., & Giordano, A. (2000) · Emerging Therapeutic Targets · doi:10.1517/14728222.4.6.765 · Cited by 11
Dienes, H. P., Baldus, S. E., Hölscher, A. H., Drebber, U., Landsberg, S., Schneider, P. M., Mönig, S., & Wangenheim, C. V. S.-V. (2008) · Molecular Medicine Reports · doi:10.3892/mmr.1.1.27 · Cited by 10
Lee, J. U., Sul, H. J., & Son, J. W. (2012) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2012.73.1.11 · Cited by 10
Analysis of p16INK4A gene promoter in male germ-cell tumors: identification of a new point mutation
Fombonne, J., Devouassoux‐Shisheboran, M., Bouvier, R., Droz, J., Benahmed, M., & Krantic, S. M. (2004) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2004.08.005 · Cited by 9
Nuclear protein patterns in normal T-lymphocytes and lymphoblastoid cells.
Estañol, J. M., Agell, N., & Bachs, O. (1997) · PubMed · Cited by 10
Contribution of the dual coding capacity of the p16INK4a/MTS1/CDK2 locus to human malignancies
Larsen, C. (1997) · Springer eBooks · doi:10.1007/978-1-4615-5371-7_9 · Cited by 14
Nylandsted, J., Rohde, M., Bártek, J., & Strauss, M. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01089-8 · Cited by 10
Fahham, N., Sardari, S., Ostad, S. N., Vaziri, B., & Ghahremani, M. H. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22892 · Cited by 12
Cyclin D1 Gene Amplification and p16 Gene Deletion in Patients With Esophageal Carcinosarcoma
Suzuki, H., Fujioka, Y., & Nagashima, K. (1998) · Diagnostic Molecular Pathology · doi:10.1097/00019606-199810000-00004 · Cited by 9
The D-Type Cyclins: A Historical Perspective
Sherr, C. J., & Siciński, P. (2017) · Current cancer research · doi:10.1007/978-3-319-64451-6_1 · Cited by 16
Qureshi, M. A., Jan, N., Dar, N. A., Hussain, M., & Andrabi, K. I. (2012) · Biomarkers · doi:10.3109/1354750x.2012.699556 · Cited by 9
HALVORSEN, O. J., Haukaas, S. A., Høisaeter, P. A., & Akslen, L. A. (1997) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/s1078-1439(97)00038-0 · Cited by 9
Chapter 25. Cell Cycle Control and Cancer
(1996) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)60464-9 · Cited by 9
Bouvier‐Labit, Civatte, Bartoli, C., Renaud, Pellissier, & Figarella‐Branger (1999) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1999.00203.x · Cited by 10
Suzuki, T., Yokozaki, H., Kuniyasu, H., Hayashi, K., Naka, K., Ono, S., Ishikawa, T., Tahara, E., & Yasui, W. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001215)88:6<992::aid-ijc24>3.0.co;2-9 · Cited by 121
Parkhitko, A. A., Singh, A., Hsieh, S. L., Hu, Y., Binari, R. C., Lord, C. J., Hannenhalli, S. S., Ryan, C. J., & Perrimon, N. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009354 · Cited by 8
Assessment of inverse correlation of p16 and pRb expression in carcinoma ex pleomorphic adenoma
Tarakji, B., Alenzi, F. Q., & Al-khuraif, A. A. (2013) · Polish Journal of Pathology · doi:10.5114/pjp.2013.36015 · Cited by 8
Clinical aspects of altered glycosylation of glycoproteins in cancer
Orntoft, T. F., & Vestergaard, E. M. (1999) · Electrophoresis · doi:10.1002/(sici)1522-2683(19990201)20:2<362::aid-elps362>3.0.co;2-v · Cited by 205
PKCα is involved in phorbol ester TPA-mediated stabilization of p14ARF
Inoue, R., & Shiraishi, T. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.117 · Cited by 9
The melanoma-associated 24 base pair duplication in p16INK4a is functionally impaired
Becker, T. M., Ayub, A. L. P., Kefford, R. F., Mann, G. J., & Rizos, H. (2005) · International Journal of Cancer · doi:10.1002/ijc.21265 · Cited by 9
A Novel Methionine-53-Valine Mutation of p16 in a Hereditary Melanoma Kindred
Yang, G., Niendorf, K. B., & Tsao, H. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23400.x · Cited by 8
Arendt, T. (2008) · Springer eBooks · doi:10.1007/978-0-387-32671-9_8 · Cited by 8
Loss of functional pRB is not a ubiquitous feature of B-cell malignancies
Sinclair, A. J., & Frost, V. J. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690408 · Cited by 8
Farrell, K., Wang, J., & Stearns, T. (2024) · eLife · doi:10.7554/elife.84875 · Cited by 11
p16INK4A-independence of Epstein–Barr virus-induced cell proliferation and virus latency
Hayes, M. J., Koundouris, A., Gruis, N. A., Bergman, W., Peters, G. G., & Sinclair, A. J. (2004) · Journal of General Virology · doi:10.1099/vir.0.79831-0 · Cited by 8
Chakraborty, C., Roychowdhury, A., Samadder, S., Roy, A. K., Mandal, R., Basu, P. S., Roychoudhury, S., & Panda, C. K. (2016) · Biochemical Journal · doi:10.1042/bcj20160323 · Cited by 7
RetractedLi, J., Qin, D., Knobloch, T. J., Tsai, M., Weghorst, C. M., Melvin, W. S., & Muscarella, P. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00577-1 · Cited by 8
Chun, T.-Y., Wendell, D. L., Gregg, D. W., & Gorski, J. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00193-2 · Cited by 8
Rosa, G. D., Caraglia, M., Salmaso, S., & ElBayoumi, T. A. (2013) · Journal of Drug Delivery · doi:10.1155/2013/604293 · Cited by 7
Absence of p16 gene (CDKN2) deletions in microdissected primary breast carcinoma specimens
Calvano, J. E., Rush, E. B., Tan, L. K., Rosen, P. P., Borgen, P. I., & Zee, K. J. V. (1997) · Annals of Surgical Oncology · doi:10.1007/bf02305555 · Cited by 6
Kim, J. H., Kim, J. H., Yu, Y. S., Kim, D. H., Kim, Y. K., & Kim, K. (2008) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e31816e232d · Cited by 7
Pocket protein function in melanocyte homeostasis and neoplasia
Tonks, I. D., Hayward, N. K., & Kay, G. F. (2006) · Pigment Cell Research · doi:10.1111/j.1600-0749.2006.00321.x · Cited by 6
Forsterová, K., Votavová, H., Schwarz, J., Karban, J., Štuka, Č., & Trněný, M. (2010) · Folia Biologica · doi:10.14712/fb2010056040158 · Cited by 6
Tawfik, O. W., Davis, M., Díaz, F. J., & Fan, F. (2016) · Acta Cytologica · doi:10.1159/000446207 · Cited by 6
Morel, A. P., Unsal, K., Çağatay, T., Ponchel, F., Carr, B. I., & Öztürk, M. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80366-9 · Cited by 7
Khare, L., Astrinidis, A., Senapedis, W. T., Adams, P. D., & Henske, E. P. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.9.676 · Cited by 7
Carnero, A. (2000) · Revista de Oncología · doi:10.1007/bf02978297 · Cited by 6
Wrede, N., Hoffmann, I., Vollbrecht, C., Koch, I., Wolkenstein, P., Klauschen, F., Capper, D., von Laffert, M., & Jurmeister, P. S. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153689 · Cited by 4
Lo, J. A., & Fisher, D. E. (2014) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-4939-2143-0_2 · Cited by 4
Pre-clinical Studies with Tumor Suppressor Genes
Seth, P. K. (2002) · Advances in experimental medicine and biology · doi:10.1007/0-306-46817-4_17 · Cited by 4
Thomas, N. S. B. (2004) · CRC Press eBooks · doi:10.1201/b14440-5 · Cited by 5
Erratum: Chromatin-remodelling factor CHRAC contains the ATPases ISWI and topoisomerase II
Varga‐Weisz, P., Wilm, M. S., Bonte, E. J., Dumas, K., Mann, M., & Becker, P. B. (1997) · Nature · doi:10.1038/39940 · Cited by 4
Lysine Acetyltransferase 6 in Health and Disease
Tan, Y., Wang, J., & Ma, F. (2025) · MedComm · doi:10.1002/mco2.70520 · Cited by 7
Yang, T., Zhou, Q., Bei, Y., Meng, D., Ai, S., Zhang, Y., Zhang, J., Liu, L., Chen, H., Pan, X., et al. (2026) · EMBO Reports · doi:10.1038/s44319-025-00688-y · Cited by 5
DNA methylation: its role in lung carcinogenesis and therapeutic implications
Santos, E. S., Raez, L. E., DeCesare, T., & Singal, R. (2005) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.5.4.667 · Cited by 3
Relationship of HPVL1 and p16 expression with different cervical lesions
Wu, H., Huirong, S., & Lingfei, K. (2011) · Scientific Research and Essays · doi:10.5897/sre11.845 · Cited by 5
Gabeeva, N., Koroleva, D. A., Belyaeva, A. V., Chernova, N. G., Kuzmina, L. A., Sudarikov, A. B., Обухова, Т. Н., Kovrigina, A. M., Zvonkov, E. E., & Vg, S. (2017) · Terapevticheskii arkhiv · doi:10.17116/terarkh201789785-92 · Cited by 3
The Growth-Inhibitory Effects of TGFβ
Herrera, R. E. (1998) · Progress in molecular and subcellular biology · doi:10.1007/978-3-642-72149-6_2 · Cited by 3
The retinoblastoma protein: More than meets the eyes
Skapek, S. X., Qian, Y., & Lee, E. Y.-H. P. (1997) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(96)00033-x · Cited by 3
Wei, X., Shi, J., Lin, Q., Ma, X., Pang, Y., Mao, H., Li, R., Lu, W., Wang, Y., & Liu, P. (2020) · Research Square · doi:10.21203/rs.3.rs-117480/v1 · Cited by 3
Nanobodies restore stability to cancer-associated mutants of tumor suppressor protein p16INK4a
Burbidge, O., Pastok, M. W., Papini, D., Hodder, S. L., Zenkevičiūtė, G., Tan, K. Z. J., Turberville, S., Noble, M. E. M., Endicott, J., & Itzhaki, L. S. (2025) · Structure · doi:10.1016/j.str.2025.07.017 · Cited by 3
The COOH terminus of p18INK4C distinguishes function from p16INK4A.
Gump, J. M., Turner, S. T., & Koh, J. (2001) · PubMed · Cited by 4
Inherited Gene Mutations in Melanoma
Pho, L. N., Champine, M., Leachman, S. A., & Kohlmann, W. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3554-3_5 · Cited by 2
Molecular Pathology and Genomics of Melanoma
Griewank, K., Murali, R., & Wiesner, T. (2018) · Springer eBooks · doi:10.1007/978-3-319-46029-1_41-1 · Cited by 2
Alam, M. N. U. (2019) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2019.100208 · Cited by 2
Mechanismen der Entstehung genetisch bedingter Krebsformen
Scherneck, S., & Kölble, K. (1998) · Springer eBooks · doi:10.1007/978-3-642-80362-8_1 · Cited by 2
Malkin, D. M., & Barlow, J. W. (2001) · Informa Healthcare eBooks · doi:10.1201/9780203904237.ch1 · Cited by 3
Farrell, K., Wang, J., & Stearns, T. (2023) · eLife · doi:10.7554/elife.84875.1 · Cited by 2
Farrell, K., Wang, J., & Stearns, T. (2024) · eLife · doi:10.7554/elife.84875.2 · Cited by 2
Zouheir, Y., Fechtali, T., & Gnaoui, N. E. (2015) · Cited by 1
Altered Signal Transduction Pathways in Melanoma
Lau, E. K., & Ronai, Z. A. (2011) · Springer eBooks · doi:10.1007/978-3-7091-0371-5_7 · Cited by 1
Borroni, R. G., Manganoni, A. M., Grassi, S., Grasso, M., Diegoli, M., Giorgianni, C., Favalli, V., Pavoni, L., Cespa, M., & Arbustini, E. (2017) · Melanoma Research · doi:10.1097/cmr.0000000000000324 · Cited by 3
Mir, M. A., & Sofi, S. (2023) · Springer eBooks · doi:10.1007/978-981-19-8911-7_4 · Cited by 4
Kamb, A., & McCormack, K. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-230-2_8 · Cited by 1
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Saffroy, R., Lemoine, A., Debuire, B., & Brousse, P. (2004) · Cited by 1
Molecular Pathology and Genomics of Melanoma
Griewank, K., Murali, R., & Wiesner, T. (2020) · Springer eBooks · doi:10.1007/978-3-030-05070-2_41 · Cited by 3
The role of genetics in the prevention of skin cancer
Whiteman, D. C., & Neale, R. Ε. (2004) · Cancer prevention, cancer causes · doi:10.1007/978-94-017-0511-0_7 · Cited by 2
Wu, C.-M. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i20.2927 · Cited by 1
CDKN2a (cyclin dependent kinase 2a / p16)
Saffroy, R., Lemoine, A., & Debuire, B. (2011) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/38488 · Cited by 1
Vaccinia virus modulates the host cell cycle to promote infection
Martin, C. K. (2019) · UCL Discovery (University College London) · Cited by 1
Kato, J., Tomoda, K., Arata, Y., Tanaka, T., & Yoneda‐Kato, N. (2002) · Elsevier eBooks · doi:10.1016/b978-012476249-7/50007-2 · Cited by 3
Farrell, K., Wang Jennifer, T., & Stearns, T. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.08.515699 · Cited by 1
Ink4a Locus: Beyond Cell Cycle
Enders, G. H. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0711-0_10
Transcription regulation of human genes: Novel aspects and mechanisms
Denissov, S. (2010) · Radboud Repository (Radboud University)
dos Santos, A. B. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2013.tde-05112013-162203
Regulation of Mammalian G1 Cyclin Dependent Kinase Complexes by Transforming Growth Factor-ß
Taipale, M. (1999) · Helda - University of Helsinki Institutional Repository
Lee, W.-J. (2007) · Journal of Life Science · doi:10.5352/jls.2007.17.4.522
Genetic Determinants of Susceptibility to UV Light-Associated Skin Cancer
Sprecher, E. (2004) · Exogenous Dermatology · doi:10.1159/000091899
A green fluorescent protein tool for cell-cycle research
Vermaas, E., & Fattaey, A. (1998) · Technical Tips Online · doi:10.1016/s1366-2120(08)70085-0
Trevisan, G., Sclaunich, S., Bonin, S., & Stanta, G. (1997) · Journal of the European Academy of Dermatology and Venereology · doi:10.1016/s0926-9959(97)00037-8
Arruda, G. (2011) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Oncogenic Aberrations of pj6INK4/CDKN2 an(j Cyclin Dl Cooperate to Deregulate G! Control1
Lukáš, J., Aagaard, L., Strauss, M., & Bui-lek, J. (1995)
Forsterová, K., Votavová, H., Schwarz, J., Karban, J., & Trněný, M. (2010)
~53 but not ~16~~~ induces growth arrest in retinoblastomadeficient hepatocelhilar carcinoma cells
Morel, A., Unsal, K., Çağatay, T., Ponchel, F., Carr, B. I., & Öztürk, M. (2000)
GRM1, a potential target for human melanoma
Wall, B. (2013) · Rutgers University Community Repository (Rutgers University) · doi:10.7282/t36m35h3
Wu, C.-M. (2003) · World Journal of Gastroenterology · doi:10.3748/wjg.v9.i12.2650
Cell Cycle Regulatory Mechanisms in Head and Neck Squamous Cell Carcinoma
Yeudall, W. A., & Wrighton, K. H. (2003) · Elsevier eBooks · doi:10.1016/b978-012239990-9/50009-6 · Cited by 1
Functional implications of a cancer associated p16INK4A mutation insilico
Qureshi, M. A., Jan, N., & Andrabi, K. I. (2013) · Journal of Computational Intelligence in Bioinformatics · doi:10.37622/jcib/6.1.2013.35-48
Sherr, C. J. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050534 · Cited by 1
Bartkowiak-Wieczorek, J., Kujawski, R., Bogacz, A., & Ożarowski, M. (2015) · Journal of Medical Science · doi:10.20883/medical.e23
p16 and ARF: Crossroads of Tumorigenesis
Yarbrough, W. G., & Xiong, Y. (2002) · Elsevier eBooks · doi:10.1016/b0-12-227555-1/00185-4
P16INK4a Expression of Uterine Cervical Biopsy Specimen in SBMCH
Devi, T. S., & Mary Lilly, S. (2021) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2021/v33i20a31343
A novel role of cyclinD1 and p16 in clinical pathology and prognosis of childhood medulloblastoma
ZhaoTao, X., He, S., & Zhu, L. (2010)
Altered Signal Transduction Pathways in Melanoma
Chéli, Y., Lau, E. K., & Ronai, Z. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-41319-8_7
Garbe, C., & Schittek, B. (2001) · Springer eBooks · doi:10.1007/978-3-642-56889-3_4
Weintraub, S. J. (1998) · Humana Press eBooks · doi:10.1007/978-1-59259-726-0_40
Metadata
- Authors
- Koh, J., Enders, G. H., David Dynlacht, B., & Harlow, E.
- Affiliations
- Massachusetts General Hospital (US)
- ORCID
- Koh, James
- Venue
- Nature
- Published
- 1995-06
- Volume
- 375
- Issue
- 6531
- Pages
- 506-510
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2035882662
- Cited by
- 516
- References
- 26
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 8 · 2022: 2 · 2021: 9 · 2020: 6 · 2019: 5 · 2018: 5 · 2017: 10 · 2016: 11 · 2015: 9 · 2014: 9 · 2013: 14 · 2012: 8
- FWCI
- 25.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- p16, tumour suppressor, cyclin-dependent kinase inhibitors, G1 cell cycle arrest, retinoblastoma protein, familial melanoma, tumor progression, cell cycle regulation
- MeSH terms
- Alleles, Animals, Carrier Proteins, Cell Line, Humans, Mutation, Recombinant Proteins, Transfection, Tumor Cells, Cultured, Genes, Tumor Suppressor, G1 Phase, 3T3 Cells, Cyclin-Dependent Kinase Inhibitor p16, Protein Kinase Inhibitors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.